Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Form 13F-NT LADENBURG THALMANN ASSET For: Sep 30
-
GrowGeneration (GRWG) PT Raised to $27 at Ladenburg Thalmann, Following Earnings
-
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Hosting Webcast for Discussion of Phase 2 Clinical Trial Design
-
CNS Pharmaceuticals to Discuss Phase 2 Clinical Trial Design to be Submitted for FDA Review in Webcast at 4:30 PM ET Today
-
GrowGeneration Reports Record Third Quarter 2020 Financial Results
-
PowerFleet (PWFL) PT Raised to $8.50 at Ladenburg Thalmann, Following Earnings
-
Sachem Capital Corp. (SACH) PT Raised to $4.50 at Ladenburg Thalmann, Following Earnings
-
Applied UV (AUVI) Announces Pricing of $6.4 Million Underwritten Public Offering at $5.25/sh
-
Applied UV, Inc. Announces Pricing of $6.4 Million Underwritten Public Offering
-
Aptevo Therapeutics (APVO) PT Raised to $64 at Ladenburg Thalmann
-
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar
-
CNS Pharmaceuticals (CNSP) Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review
-
CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review
-
Gaming and Leisure Properties, Inc. Announces Underwriters’ Exercise of Greenshoe Option in Public Offering of Common Stock
-
Analysts' View: Markets hold breath as final votes tallied in U.S. battleground states
-
Vector Group Reports Third Quarter 2020 Financial Results
-
New Beginnings Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
Advisor Group and Royal Alliance Announce Recruitment of Pacific Capital Resource Group
-
Forte Biosciences Announces Closing of $46.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Ladenburg Thalmann Upgrades Orchid Island Capital (ORC) to Buy, Following Earnings
-
Stellus Capital (SCM) PT Lowered to $9.50 at Ladenburg Thalmann, Following Earnings
-
Gaming and Leisure Properties (GLPI) Prices 8M Share Common Offering at $36.25/Sh
-
New Beginnings Acquisition Corp. (NBA) Prices 10M Unit IPO at $10/Unit
-
Gaming and Leisure Properties, Inc. Announces Pricing of Public Offering of Common Stock
-
New Beginnings Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Forte Biosciences (FBRX) Announces Pricing of $40 Million Public Offering of Common Stock at $28.50/sh
-
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
-
Forte Biosciences (FBRX) Announces Proposed Public Offering of Common Stock
-
Forte Biosciences Announces Proposed Public Offering of Common Stock
-
VICI Properties Inc. (VICI) PT Raised to $26.50 at Ladenburg Thalmann, Ahead Of Earnings
-
Dynex Capital (DX) PT Raised to $18 at Ladenburg Thalmann, Following Earnings
-
miRagen Therapeutics (MGEN) Announces Acquisition of Viridian Therapeutics
-
miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
-
Advisor Group Launches My Mentor Connect To Promote And Facilitate Mentorships Between The Next Gen And Experienced Financial Professionals
-
Advisor Group Commences Virtual National Conference With Launch Of Its Continuity Coverage And Acquisition Financing Program
-
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
-
Getty Realty (GTY) PT Raised to $36 at Ladenburg Thalmann
-
Sachem Capital Corp. Announces Closing of Public Offering of $14 Million of 7.75% Notes
-
Interpace Diagnostics Group Inc (IDXG) PT Lowered to $11.50 at Ladenburg Thalmann, Following Earnings
-
Sachem Capital Corp. Prices Registered Public Offering of $14 Million of 7.75% Notes
-
Sachem Capital Corp. (SACH) Announces Registered Public Offering of 7.75% Notes
-
Sachem Capital Corp. Announces Registered Public Offering of 7.75% Notes
-
Tarsus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise by the Underwriters of Option to Purchase Additional Shares
-
Tarsus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise by the Underwriters of Option to Purchase Additional Shares
-
Tarsus Pharmaceuticals (TARS) IPO Opens Modestly Higher
-
Tarsus Pharmaceuticals, Inc. (TARS) Prices 5.5M Share IPO at $16/Sh
-
Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering
-
Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering
-
Advisor Group And Royal Alliance Announce Recruitment Of Houston-Based Mint Wealth Management
-
Artelo Biosciences, Inc. Announces Closing of $7.6 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option

